Preventer Asthma Inhaler - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510253642

Publication Date:

October 8, 2024

Pages:

141

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Preventer Asthma Inhaler was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Preventer Asthma Inhaler was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preventer Asthma Inhaler was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Preventer Asthma Inhaler was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Preventer Asthma Inhaler include GSKpro, 3M, Aristopharma, Intas Pharmaceuticals, Sensirion, Adherium, AstraZeneca, Boehringer Ingelheim and Glenmark, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Preventer Asthma Inhaler, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Preventer Asthma Inhaler by region & country, by Type, and by Application.
The Preventer Asthma Inhaler market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventer Asthma Inhaler.
Market Segmentation
By Company
GSKpro
3M
Aristopharma
Intas Pharmaceuticals
Sensirion
Adherium
AstraZeneca
Boehringer Ingelheim
Glenmark
Vectura
Chiesi
Cipla
Hovione
Mylan
Merck
Segment by Type:
Metered-dose (MDIs)
Breath-actuated Inhalers (BAIs)
Dry Powder Inhalers (DPIs)
Segment by Application
Personal
Hospital
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Preventer Asthma Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Preventer Asthma Inhaler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Preventer Asthma Inhaler in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Preventer Asthma Inhaler Product Introduction
1.2 Global Preventer Asthma Inhaler Market Size Forecast
1.2.1 Global Preventer Asthma Inhaler Sales Value (2019-2030)
1.2.2 Global Preventer Asthma Inhaler Sales Volume (2019-2030)
1.2.3 Global Preventer Asthma Inhaler Sales Price (2019-2030)
1.3 Preventer Asthma Inhaler Market Trends & Drivers
1.3.1 Preventer Asthma Inhaler Industry Trends
1.3.2 Preventer Asthma Inhaler Market Drivers & Opportunity
1.3.3 Preventer Asthma Inhaler Market Challenges
1.3.4 Preventer Asthma Inhaler Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Preventer Asthma Inhaler Players Revenue Ranking (2023)
2.2 Global Preventer Asthma Inhaler Revenue by Company (2019-2024)
2.3 Global Preventer Asthma Inhaler Players Sales Volume Ranking (2023)
2.4 Global Preventer Asthma Inhaler Sales Volume by Company Players (2019-2024)
2.5 Global Preventer Asthma Inhaler Average Price by Company (2019-2024)
2.6 Key Manufacturers Preventer Asthma Inhaler Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Preventer Asthma Inhaler Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Preventer Asthma Inhaler
2.9 Preventer Asthma Inhaler Market Competitive Analysis
2.9.1 Preventer Asthma Inhaler Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Preventer Asthma Inhaler Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventer Asthma Inhaler as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Metered-dose (MDIs)
3.1.2 Breath-actuated Inhalers (BAIs)
3.1.3 Dry Powder Inhalers (DPIs)
3.2 Global Preventer Asthma Inhaler Sales Value by Type
3.2.1 Global Preventer Asthma Inhaler Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Preventer Asthma Inhaler Sales Value, by Type (2019-2030)
3.2.3 Global Preventer Asthma Inhaler Sales Value, by Type (%) (2019-2030)
3.3 Global Preventer Asthma Inhaler Sales Volume by Type
3.3.1 Global Preventer Asthma Inhaler Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Preventer Asthma Inhaler Sales Volume, by Type (2019-2030)
3.3.3 Global Preventer Asthma Inhaler Sales Volume, by Type (%) (2019-2030)
3.4 Global Preventer Asthma Inhaler Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Personal
4.1.2 Hospital
4.1.3 Clinics
4.2 Global Preventer Asthma Inhaler Sales Value by Application
4.2.1 Global Preventer Asthma Inhaler Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Preventer Asthma Inhaler Sales Value, by Application (2019-2030)
4.2.3 Global Preventer Asthma Inhaler Sales Value, by Application (%) (2019-2030)
4.3 Global Preventer Asthma Inhaler Sales Volume by Application
4.3.1 Global Preventer Asthma Inhaler Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Preventer Asthma Inhaler Sales Volume, by Application (2019-2030)
4.3.3 Global Preventer Asthma Inhaler Sales Volume, by Application (%) (2019-2030)
4.4 Global Preventer Asthma Inhaler Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Preventer Asthma Inhaler Sales Value by Region
5.1.1 Global Preventer Asthma Inhaler Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Preventer Asthma Inhaler Sales Value by Region (2019-2024)
5.1.3 Global Preventer Asthma Inhaler Sales Value by Region (2025-2030)
5.1.4 Global Preventer Asthma Inhaler Sales Value by Region (%), (2019-2030)
5.2 Global Preventer Asthma Inhaler Sales Volume by Region
5.2.1 Global Preventer Asthma Inhaler Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Preventer Asthma Inhaler Sales Volume by Region (2019-2024)
5.2.3 Global Preventer Asthma Inhaler Sales Volume by Region (2025-2030)
5.2.4 Global Preventer Asthma Inhaler Sales Volume by Region (%), (2019-2030)
5.3 Global Preventer Asthma Inhaler Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Preventer Asthma Inhaler Sales Value, 2019-2030
5.4.2 North America Preventer Asthma Inhaler Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Preventer Asthma Inhaler Sales Value, 2019-2030
5.5.2 Europe Preventer Asthma Inhaler Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Preventer Asthma Inhaler Sales Value, 2019-2030
5.6.2 Asia Pacific Preventer Asthma Inhaler Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Preventer Asthma Inhaler Sales Value, 2019-2030
5.7.2 South America Preventer Asthma Inhaler Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Preventer Asthma Inhaler Sales Value, 2019-2030
5.8.2 Middle East & Africa Preventer Asthma Inhaler Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Preventer Asthma Inhaler Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Preventer Asthma Inhaler Sales Value
6.2.1 Key Countries/Regions Preventer Asthma Inhaler Sales Value, 2019-2030
6.2.2 Key Countries/Regions Preventer Asthma Inhaler Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Preventer Asthma Inhaler Sales Value, 2019-2030
6.3.2 United States Preventer Asthma Inhaler Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Preventer Asthma Inhaler Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Preventer Asthma Inhaler Sales Value, 2019-2030
6.4.2 Europe Preventer Asthma Inhaler Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Preventer Asthma Inhaler Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Preventer Asthma Inhaler Sales Value, 2019-2030
6.5.2 China Preventer Asthma Inhaler Sales Value by Type (%), 2023 VS 2030
6.5.3 China Preventer Asthma Inhaler Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Preventer Asthma Inhaler Sales Value, 2019-2030
6.6.2 Japan Preventer Asthma Inhaler Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Preventer Asthma Inhaler Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Preventer Asthma Inhaler Sales Value, 2019-2030
6.7.2 South Korea Preventer Asthma Inhaler Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Preventer Asthma Inhaler Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Preventer Asthma Inhaler Sales Value, 2019-2030
6.8.2 Southeast Asia Preventer Asthma Inhaler Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Preventer Asthma Inhaler Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Preventer Asthma Inhaler Sales Value, 2019-2030
6.9.2 India Preventer Asthma Inhaler Sales Value by Type (%), 2023 VS 2030
6.9.3 India Preventer Asthma Inhaler Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GSKpro
7.1.1 GSKpro Company Information
7.1.2 GSKpro Introduction and Business Overview
7.1.3 GSKpro Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.1.4 GSKpro Preventer Asthma Inhaler Product Offerings
7.1.5 GSKpro Recent Development
7.2 3M
7.2.1 3M Company Information
7.2.2 3M Introduction and Business Overview
7.2.3 3M Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.2.4 3M Preventer Asthma Inhaler Product Offerings
7.2.5 3M Recent Development
7.3 Aristopharma
7.3.1 Aristopharma Company Information
7.3.2 Aristopharma Introduction and Business Overview
7.3.3 Aristopharma Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Aristopharma Preventer Asthma Inhaler Product Offerings
7.3.5 Aristopharma Recent Development
7.4 Intas Pharmaceuticals
7.4.1 Intas Pharmaceuticals Company Information
7.4.2 Intas Pharmaceuticals Introduction and Business Overview
7.4.3 Intas Pharmaceuticals Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Intas Pharmaceuticals Preventer Asthma Inhaler Product Offerings
7.4.5 Intas Pharmaceuticals Recent Development
7.5 Sensirion
7.5.1 Sensirion Company Information
7.5.2 Sensirion Introduction and Business Overview
7.5.3 Sensirion Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sensirion Preventer Asthma Inhaler Product Offerings
7.5.5 Sensirion Recent Development
7.6 Adherium
7.6.1 Adherium Company Information
7.6.2 Adherium Introduction and Business Overview
7.6.3 Adherium Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Adherium Preventer Asthma Inhaler Product Offerings
7.6.5 Adherium Recent Development
7.7 AstraZeneca
7.7.1 AstraZeneca Company Information
7.7.2 AstraZeneca Introduction and Business Overview
7.7.3 AstraZeneca Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.7.4 AstraZeneca Preventer Asthma Inhaler Product Offerings
7.7.5 AstraZeneca Recent Development
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Company Information
7.8.2 Boehringer Ingelheim Introduction and Business Overview
7.8.3 Boehringer Ingelheim Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Boehringer Ingelheim Preventer Asthma Inhaler Product Offerings
7.8.5 Boehringer Ingelheim Recent Development
7.9 Glenmark
7.9.1 Glenmark Company Information
7.9.2 Glenmark Introduction and Business Overview
7.9.3 Glenmark Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Glenmark Preventer Asthma Inhaler Product Offerings
7.9.5 Glenmark Recent Development
7.10 Vectura
7.10.1 Vectura Company Information
7.10.2 Vectura Introduction and Business Overview
7.10.3 Vectura Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Vectura Preventer Asthma Inhaler Product Offerings
7.10.5 Vectura Recent Development
7.11 Chiesi
7.11.1 Chiesi Company Information
7.11.2 Chiesi Introduction and Business Overview
7.11.3 Chiesi Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Chiesi Preventer Asthma Inhaler Product Offerings
7.11.5 Chiesi Recent Development
7.12 Cipla
7.12.1 Cipla Company Information
7.12.2 Cipla Introduction and Business Overview
7.12.3 Cipla Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Cipla Preventer Asthma Inhaler Product Offerings
7.12.5 Cipla Recent Development
7.13 Hovione
7.13.1 Hovione Company Information
7.13.2 Hovione Introduction and Business Overview
7.13.3 Hovione Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Hovione Preventer Asthma Inhaler Product Offerings
7.13.5 Hovione Recent Development
7.14 Mylan
7.14.1 Mylan Company Information
7.14.2 Mylan Introduction and Business Overview
7.14.3 Mylan Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Mylan Preventer Asthma Inhaler Product Offerings
7.14.5 Mylan Recent Development
7.15 Merck
7.15.1 Merck Company Information
7.15.2 Merck Introduction and Business Overview
7.15.3 Merck Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Merck Preventer Asthma Inhaler Product Offerings
7.15.5 Merck Recent Development
8 Industry Chain Analysis
8.1 Preventer Asthma Inhaler Industrial Chain
8.2 Preventer Asthma Inhaler Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Preventer Asthma Inhaler Sales Model
8.5.2 Sales Channel
8.5.3 Preventer Asthma Inhaler Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

GSKpro
3M
Aristopharma
Intas Pharmaceuticals
Sensirion
Adherium
AstraZeneca
Boehringer Ingelheim
Glenmark
Vectura
Chiesi
Cipla
Hovione
Mylan
Merck

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂